TAM
AGN

Tocqueville Asset Management’s Allergan Inc AGN Stock Holding History

Tocqueville Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-405,583
Closed -$86.2M – 1014
2014
Q4 		$86.2M Sell
405,583
-43,669
-10% -$8.68M 0.93% 14
2014
Q3 		$80.1M Sell
449,252
-38,989
-8% -$6.48M 0.89% 20
2014
Q2 		$82.6M Sell
488,241
-63,825
-12% -$9.94M 0.8% 24
2014
Q1 		$68.5M Sell
552,066
-1,945
-0.4% -$237K 0.9% 21
2013
Q4 		$61.5M Buy
554,011
+148,825
+37% +$14.2M 0.83% 26
2013
Q3 		$36.6M Buy
405,186
+385,385
+1,946% +$34.6M 0.46% 72
2013
Q2 		$1.67M Buy
+19,801
New +$2.05M 0.02% 438

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Tocqueville Asset Management's AGN Position: Q1 2015 in Review

Tocqueville Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 405,583 shares — an estimated $86.2M sold.

Tocqueville Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $86.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Tocqueville Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 405,583 Allergan Inc shares in Q1 2015, an estimated $86.2M.
  • Tocqueville Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Tocqueville Asset Management's Allergan Inc position peaked at $86.2M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Tocqueville Asset Management's 13F filing for Q1 2015, filed 30 Apr 2015.